This site is intended for health professionals only
Friday 26 April 2019
Share |

Ignore Tamiflu expiry date: experts

The European Commission is expected to approve the extension of Tamiflu's five-year shelf life by two years, it has been revealed.

The move will apply to all newly manufactured Tamiflu capsules and follows recommendations from the European Medicines Agency.

In the event of a pandemic being declared by the World Health Organisation, the London-based watchdog has also recommended that the five-year expiry date of existing Tamiflu capsules be ignored.

A statement from the agency said: "In view of the recent outbreak of the novel influenza A/H1N1 virus, the European Medicines Agency has also reviewed ways to use Tamiflu capsules in case of a shortage.

"The Agency's Committee for Medicinal Products for Human Use recommended that Tamiflu capsules that are already on the market may be used for up to two more years after their current five-year expiry date during a declared pandemic.

"Patients who have Tamiflu capsules that have recently expired should not dispose of them because they might be needed during a novel influenza A/H1N1 pandemic."

The advice was announced after a study of how to prevent shortages of antiviral medicines key in managing flu pandemics – such as Tamiflu, according to the statement.

Copyright Press Association 2009

European Medicines Agency

Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher